New York, Feb 9, 2026, 15:41 EST — Regular session
- Rocket Lab shares climbed roughly 6% in late-afternoon trading, bouncing after a volatile drop earlier.
- High-beta “space” stocks found firmer footing as tech’s rebound lent a boost to sentiment.
- Attention now turns to Feb. 26 results, and whether there’s any fresh word on the Neutron rocket schedule.
Rocket Lab Corp climbed 5.95% to $76.63 late Monday, after bouncing from $70.75 up to as high as $76.78 during the session. Roughly 13.9 million shares changed hands, per Investing.com data.
Why does the bounce matter? Rocket Lab’s been acting as a risk gauge—spiking and tumbling in step with rate swings and market mood shifts. Shares have swung between $14.71 and $99.58 in the past 52 weeks, underscoring just how fleeting momentum can be.
There’s something else coming up for investors: Rocket Lab has scheduled its Q4 and full-year 2025 earnings report and call for Feb. 26, according to its investor relations page.
Some support came from the wider market. Tech names pulled U.S. stocks higher Monday, with buyers stepping in after the recent selloff—“it seems to be the traditional buy-the-dip by retail investors,” Wealthspire Advisors’ Oliver Pursche told Reuters. Market participants have their eyes on U.S. payrolls due Wednesday and consumer price inflation figures coming Friday. Reuters
Rocket Lab wasn’t the only space stock on the move. AST SpaceMobile ticked up roughly 0.6%, Intuitive Machines popped nearly 13%, and Virgin Galactic traded about 5.5% higher during the afternoon.
Rocket Lab shares have been swinging sharply. The stock jumped 9.05% in the previous session, data from StockInvest.us show, coming off a stretch where it dropped in six out of the past 10 sessions.
Washington’s been a drag here. Rocket Lab dropped over 7% last week, after Congress opted not to back the company’s 2031 Mars sample-return mission proposal, according to Investors.com.
The main argument for staying bullish hinges on Rocket Lab’s pipeline of government and private-sector contracts. Back in December, the company landed an $816 million prime contract from the U.S. Space Development Agency: the job is to design and build 18 satellites for a missile-defense network.
Execution is still the other key lever here. Back in January, Rocket Lab said it would give an update on the Neutron timeline during its fourth-quarter 2025 earnings call next February, following a test snag with the Neutron Stage 1 tank.
The stock isn’t immune to setbacks. Miss revenue or margin targets, offer a weaker outlook, or stumble again on Neutron’s schedule—any of those could rattle a name trading on the assumption of smooth execution. There’s not much tolerance here for surprises.
Rocket Lab’s numbers hit on Feb. 26. Investors will be looking for updates on Neutron’s timeline, any hints in the guidance, and how leadership sees demand shaping up through 2026. U.S. payrolls and inflation data out this week could shake up the high-growth names all the way through Tuesday’s session.
